Cipla’s shares are in focus as the company reported a 15% YoY increase in consolidated net profit to Rs 1,303 crore for Q2 2024. Revenue rose 6% to Rs 7,051 crore, with EBITDA growing 12%. Despite mixed outlooks from analysts, including BofA’s ‘Underperform’ and UBS’s ‘Buy’ rating, concerns about market challenges and product launch delays persist.
| Subscribe To Our Free Newsletter |
